NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

臨床試驗管理的全球市場的預測:2021年∼2028年

Global Clinical Trial Management Market Forecast 2021-2028

出版商 Inkwood Research 商品編碼 1003293
出版日期 內容資訊 英文 204 Pages
商品交期: 2-3個工作天內
價格
臨床試驗管理的全球市場的預測:2021年∼2028年 Global Clinical Trial Management Market Forecast 2021-2028
出版日期: 2021年05月03日內容資訊: 英文 204 Pages
簡介

全球臨床試驗管理市場,2021年∼2028年的預測期間內將以11.77%的年複合成長率成長。重要的成長促進因素,是臨床試驗的數量增加,慢性疾病的發生率劇增,臨床試驗管理軟體的優點,研究開發等。

本報告提供全球臨床試驗管理市場相關調查分析,市場動態,各市場區隔的市場分析,各地區分析,主要企業相關的系統性資訊。

目錄

第1章 調查範圍和調查手法

第2章 摘要整理

第3章 市場動態

  • 親市場分析:醫療
  • 市場範圍
  • 主要促進因素
  • 主要阻礙因素

第4章 主要分析

  • COVID-19對臨床試驗管理市場的影響
  • 主要的市場趨勢
  • 波特的五力分析
  • 機會矩陣
  • 業者情勢

第5章 市場:各終端用戶

  • 製藥企業、生物醫藥品企業
  • 臨床研究機關
  • 醫護人員

第6章 市場:各產品類型

  • 企業為基礎
  • 網站為基礎

第7章 市場:各部署模型

  • Web為基礎
  • 內部部署
  • 雲端基礎

第8章 市場:各零件

  • 軟體
  • 硬體設備
  • 服務

第9章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第10章 競爭情形

  • 主要策略的發展
  • 企業簡介
    • ADVARRA (FORTE RESEARCH SYSTEMS INC)
    • ARISGLOBAL LLC
    • BIOCLINICA INC
    • BIO-OPTRONICS INC
    • IBM CORPORATION
    • MEDIDATA SOLUTIONS INC
    • MEDNET SOLUTIONS INC
    • ORACLE CORPORATION
    • PAREXEL INTERNATIONAL CORPORATION
    • VEEVA SYSTEMS INC
目錄
Product Code: 24387

KEY FINDINGS

The global clinical trial management market is set to project a CAGR of 11.77% during the forecast period, 2021-2028. The growing number of clinical trials, research & development, rising chronic disease incidences, CTM software benefits, and research & development are significant growth drivers.

MARKET INSIGHTS

Clinical trial management systems include various components that comprise services, hardware, and software. It helps in maintaining the complex data obtained from clinical trials. Clinical trials are on the rise globally, attributed to technological advancements and the growing demand for advanced drugs with fewer side effects. The discovery of new treatments is propelled by rapid innovations in data management, biotechnology, and artificial intelligence. With every new drug, treatment, and device needing to undergo clinical trial, the volume of trials continues to rise.

Moreover, medicine is changing at a fast-paced pace. There is an increasing demand for services and software to manage the piling data from the rising clinical trials. Such factors are projected to drive market growth. However, the implantation costs, security concerns, and the lack of skilled healthcare professionals hinder the market growth.

REGIONAL INSIGHTS

The global clinical trial management market growth evaluation includes the analysis of Asia-Pacific, Europe, North America, and Rest of World. North America is estimated to harbor the largest revenue share. At the same time, Asia-Pacific is set to record the highest CAGR by 2028. The market prospects of Asia-Pacific are attributed to the increasing clinical trial management product awareness and dense population base.

COMPETITIVE INSIGHTS

The market has an increasing number of market players, along with a considerable scope of innovation. Bio-Optronics Inc, Medidata Solutions Inc, Arisglobal LLC, Bioclinica Inc, etc., are among the leading companies in the market.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. PARENT MARKET ANALYSIS - HEALTHCARE
  • 3.2. MARKET SCOPE
  • 3.3. KEY DRIVERS
    • 3.3.1. OUTSOURCING OF CLINICAL TRIALS
    • 3.3.2. GROWTH IN THE NUMBER OF CLINICAL TRIALS
    • 3.3.3. AWARENESS REGARDING THE BENEFITS OF CTM SOFTWARE
    • 3.3.4. INCIDENCES OF CHRONIC DISEASES
    • 3.3.5. RESEARCH & DEVELOPMENT
  • 3.4. KEY RESTRAINTS
    • 3.4.1. SCARCITY OF SKILLED HEALTHCARE PROFESSIONALS
    • 3.4.2. COST OF IMPLEMENTATION
    • 3.4.3. SECURITY CONCERNS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON CLINICAL TRIAL MANAGEMENT MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. THREAT OF SUBSTITUTION
    • 4.3.4. THREAT OF NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY END-USER

  • 5.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 5.2. CLINICAL RESEARCH ORGANIZATIONS
  • 5.3. HEALTHCARE PROVIDERS

6. MARKET BY PRODUCT TYPE

  • 6.1. ENTERPRISE-BASED CTM
  • 6.2. SITE-BASED CTM

7. MARKET BY DEPLOYMENT MODEL

  • 7.1. WEB-BASED DEPLOYMENT
  • 7.2. ON-PREMISE DEPLOYMENT
  • 7.3. CLOUD-BASED DEPLOYMENT

8. MARKET BY COMPONENT

  • 8.1. SOFTWARE
  • 8.2. HARDWARE
  • 8.3. SERVICES

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. UNITED STATES
      • 9.1.5.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. MARKET SIZE & ESTIMATES
    • 9.2.2. KEY GROWTH ENABLERS
    • 9.2.3. KEY CHALLENGES
    • 9.2.4. KEY PLAYERS
    • 9.2.5. COUNTRY ANALYSIS
      • 9.2.5.1. UNITED KINGDOM
      • 9.2.5.2. GERMANY
      • 9.2.5.3. FRANCE
      • 9.2.5.4. ITALY
      • 9.2.5.5. RUSSIA
      • 9.2.5.6. BELGIUM
      • 9.2.5.7. POLAND
      • 9.2.5.8. REST OF EUROPE
  • 9.3. ASIA-PACIFIC
    • 9.3.1. MARKET SIZE & ESTIMATES
    • 9.3.2. KEY GROWTH ENABLERS
    • 9.3.3. KEY CHALLENGES
    • 9.3.4. KEY PLAYERS
    • 9.3.5. COUNTRY ANALYSIS
      • 9.3.5.1. CHINA
      • 9.3.5.2. JAPAN
      • 9.3.5.3. INDIA
      • 9.3.5.4. SOUTH KOREA
      • 9.3.5.5. INDONESIA
      • 9.3.5.6. THAILAND
      • 9.3.5.7. VIETNAM
      • 9.3.5.8. AUSTRALIA & NEW ZEALAND
      • 9.3.5.9. REST OF ASIA-PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. MARKET SIZE & ESTIMATES
    • 9.4.2. KEY GROWTH ENABLERS
    • 9.4.3. KEY CHALLENGES
    • 9.4.4. KEY PLAYERS
    • 9.4.5. REGION ANALYSIS
      • 9.4.5.1. LATIN AMERICA
      • 9.4.5.2. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. MERGERS & ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
  • 10.2. COMPANY PROFILES
    • 10.2.1. ADVARRA (FORTE RESEARCH SYSTEMS INC)
    • 10.2.2. ARISGLOBAL LLC
    • 10.2.3. BIOCLINICA INC
    • 10.2.4. BIO-OPTRONICS INC
    • 10.2.5. IBM CORPORATION
    • 10.2.6. MEDIDATA SOLUTIONS INC
    • 10.2.7. MEDNET SOLUTIONS INC
    • 10.2.8. ORACLE CORPORATION
    • 10.2.9. PAREXEL INTERNATIONAL CORPORATION
    • 10.2.10. VEEVA SYSTEMS INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - CLINICAL TRIAL MANAGEMENT
  • TABLE 2: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL CLINICAL RESEARCH ORGANIZATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GLOBAL CLINICAL RESEARCH ORGANIZATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL HEALTHCARE PROVIDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GLOBAL HEALTHCARE PROVIDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL ENTERPRISE-BASED CTM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: GLOBAL ENTERPRISE-BASED CTM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL SITE-BASED CTM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: GLOBAL SITE-BASED CTM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL WEB-BASED DEPLOYMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 19: GLOBAL WEB-BASED DEPLOYMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL ON-PREMISE DEPLOYMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 21: GLOBAL ON-PREMISE DEPLOYMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL CLOUD-BASED DEPLOYMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 23: GLOBAL CLOUD-BASED DEPLOYMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 25: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL SOFTWARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 27: GLOBAL SOFTWARE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL HARDWARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 29: GLOBAL HARDWARE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 31: GLOBAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 33: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 34: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 35: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 36: KEY PLAYERS OPERATING IN NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET
  • TABLE 37: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 38: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 39: KEY PLAYERS OPERATING IN EUROPE CLINICAL TRIAL MANAGEMENT MARKET
  • TABLE 40: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 41: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 42: KEY PLAYERS OPERATING IN ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET
  • TABLE 43: REST OF WORLD CLINICAL TRIAL MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 44: REST OF WORLD CLINICAL TRIAL MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 45: KEY PLAYERS OPERATING IN THE REST OF WORLD CLINICAL TRIAL MANAGEMENT MARKET
  • TABLE 46: LIST OF MERGERS & ACQUISITIONS
  • TABLE 47: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 48: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
  • FIGURE 6: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2020
  • FIGURE 10: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2021-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2021-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODEL, IN 2020
  • FIGURE 13: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2020
  • FIGURE 17: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2021-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2021-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 21: UNITED STATES CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 22: CANADA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 23: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 24: UNITED KINGDOM CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 25: GERMANY CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 26: FRANCE CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 27: ITALY CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 28: RUSSIA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 29: BELGIUM CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: POLAND CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: REST OF EUROPE CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 32: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 33: CHINA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 34: JAPAN CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 35: INDIA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 36: SOUTH KOREA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 37: INDONESIA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 38: THAILAND CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 39: VIETNAM CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 40: AUSTRALIA & NEW ZEALAND CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 41: REST OF ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 42: REST OF WORLD CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 43: LATIN AMERICA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)